Related Experiment Videos
[Modern pathogenetic-therapeutic approaches in glaucoma]
C Constantin1, D Costin, D Chiseliţă
1Clinica II Oftalmologie, Iaşi.
Oftalmologia (Bucharest, Romania : 1990)
|October 6, 2000
Abstract:
The review presents briefly the new orientations in pathogenically research of glaucoma, the actual theory of apoptosis in generating glaucomatous neuropathy. The substances and transmitters that interfere in the process of apoptosis are also discussed. It is also discussed the new neuroprotective medication. The conclusion is that this new therapy will be an adjunctive one to the classical antiglaucomatous therapy.
Insights
This review explores apoptosis in glaucoma, focusing on neuroprotective drugs. New therapies will complement existing glaucoma treatments for better outcomes.
Area of Science:
- Ophthalmology
- Neuroscience
- Cell Biology
Context:
- Glaucoma pathogenesis research is evolving.
- Understanding apoptosis is crucial for glaucomatous neuropathy.
- Current research investigates molecular mechanisms underlying optic nerve damage.
Purpose:
- To review current understanding of apoptosis in glaucoma.
- To discuss substances and transmitters involved in apoptosis.
- To introduce novel neuroprotective medications for glaucoma.
Summary:
- The review covers new directions in glaucoma pathogenesis research.
- It examines the role of apoptosis in developing glaucomatous neuropathy.
- Substances and transmitters influencing apoptosis, along with new neuroprotective drugs, are discussed.
Impact:
- Novel neuroprotective therapies are emerging for glaucoma management.
- These new treatments are expected to be adjunctive to established glaucoma therapies.
- This research may lead to improved therapeutic strategies for preserving vision in glaucoma patients.